ArticleJournal of cutaneous pathology2026
Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype.
Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype.Journal of cutaneous pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An otherwise healthy 82-year-old woman presented with recurrent, asymptomatic erythematous papulo-nodular lesions on the face and extremities. A skin biopsy revealed a dense, non-epidermotropic lymphohistiocytic infiltrate with granulomatous features and a mixed population of medium-sized atypical lymphoid cells and plasma cells. Immunohistochemistry demonstrated a predominant CD4+ T-cell population with a T-follicular helper (TFH) phenotype (PD1+, CXCL13+, BCL6+), admixed with EBV-negative monotypic B-cells. Clonality was confirmed for both T and B cells by BIOMED2 PCR, and a RHOA p.G17V mutation was identified. Next-generation sequencing revealed additional mutations in TET2 and DNMT3A. Complete staging studies showed no nodal or visceral involvement. A minimal circulating population (0.11%) of atypical CD4+ T-cells with surface CD3 loss and TFH markers was detected in peripheral blood. Based on clinical and histopathological findings, a diagnosis of primary cutaneous peripheral T-cell lymphoma with TFH phenotype (pcPTCL-TFH) was made. The patient also developed a cutaneous squamous cell carcinoma, in which a peritumoral TFH lymphoid infiltrate with the same clonal features was identified. This case illustrates the diagnostic complexity of pcPTCL-TFH and its potential overlap with systemic TFH-derived lymphomas, underscoring the need for molecular work-up and close clinical follow-up to detect possible extracutaneous progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.